More recently, studies investigated the prognostic value of stromal CAV1 expression in various cancers, and more specifically in prostate cancer, gastric cancer, pancreatic cancer, non-small-cell lung cancer, and colorectal cancer7, 10–12, 22. Here, CAV1 is linked to pancreatic neoplasm.